ClinicalTrials.Veeva

Menu

Evaluation of a Speech-to-noise Feedback Device for Treatment of Hypophonia in Parkinson's Disease

L

Lawson Health Research Institute

Status

Unknown

Conditions

Parkinson Disease

Treatments

Behavioral: Speech-to-noise feedback

Study type

Interventional

Funder types

Other

Identifiers

NCT03648749
111861 (Other Identifier)
LawsonHRI5264

Details and patient eligibility

About

This study will evaluate the effectiveness of a speech-to-noise feedback procedure for the treatment of hypophonia in Parkinson's disease. The procedure includes a device that records the sound intensity level of the wearer's speech and compares it to the noise level around them. The device will provide the wearer with feedback if their speech becomes too quiet for them to be heard by their listener.

Full description

This study will evaluate the effectiveness of a speech-to-noise feedback procedure for the treatment of hypophonia in Parkinson's disease. The procedure includes a device that records the sound intensity level of the wearer's speech and compares it to the noise level around them. The device will provide the wearer with feedback if their speech becomes too quiet for them to be heard by their listener.

Enrollment

25 estimated patients

Sex

All

Ages

45 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosed with idiopathic Parkinson's disease and hypophonia by a neurologist at least 6 months prior to participation.
  • stabilized on antiparkinsonian medication.
  • good general health.
  • pass a 40 decibel hearing screening.
  • proficient enough in English to participate in speech testing.

Exclusion criteria

  • history of stroke or an additional neurological or motor control disorder.
  • history of speech impairment that is unrelated to Parkinson's disease.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

25 participants in 1 patient group

Speech-to-noise feedback
Experimental group
Description:
A target speech-to-noise level is specified and feedback about achievement of the target level is provided
Treatment:
Behavioral: Speech-to-noise feedback

Trial contacts and locations

1

Loading...

Central trial contact

Mandar Jog, MD; Scott Adams, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems